Delivery of Self Training and Education for Stressful Situations-Telephone Version (DESTRESS-T)

This study is not yet open for participant recruitment.
Verified January 2012 by Uniformed Services University of the Health Sciences
Sponsor:
Collaborators:
Walter Reed National Military Medical Center
Information provided by (Responsible Party):
Charles Engel, Uniformed Services University of the Health Sciences
ClinicalTrials.gov Identifier:
NCT01502449
First received: December 12, 2011
Last updated: January 11, 2012
Last verified: January 2012
  Purpose

This study will evaluate a telephone-delivered cognitive-behavioral psychotherapy intervention designed for primary care treatment of combat-exposed service members with PTSD. The investigators will assess Posttraumatic Stress Disorder (PTSD) symptoms, mental health-related and occupational functioning, and symptoms of depression, anxiety, and somatization.


Condition Intervention
PTSD
Behavioral: DESTRESS-T
Other: Optimized Usual Care (OUC)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Randomized Trial of Telephonic Psychotherapy and Case Management for Combat-Related Posttraumatic Stress Disorder

Resource links provided by NLM:


Further study details as provided by Uniformed Services University of the Health Sciences:

Primary Outcome Measures:
  • Posttraumatic Stress Disorder Checklist - Civilian Version (PCL) [ Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks ] [ Designated as safety issue: No ]
    Symptoms of PTSD will be assessed using the PTSD Checklist-Civilian Version. The PCL is a self-report measure developed for measuring PTSD symptom severity and for estimating PTSD caseness when administration of a structured clinical interview is not feasible. Respondents rate PCL items on a 5-point scale ("not at all" through "extremely") to indicate the degree to which they have been bothered by each of 17 PTSD symptoms during the past month. Possible PCL scores range from 17 to 85.


Secondary Outcome Measures:
  • Medical Outcomes Survey Short-Form-12 (SF-12) [ Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks ] [ Designated as safety issue: No ]
    The SF-12 is a commonly used measure of mental and physical functional status. The 12 items in the SF-12 are a subset of those in the SF-36. The SF-12 contains one or two items from each of the eight health scales: physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality (energy/fatigue), social functioning, and role limitations due to emotional problems and mental health (psychological distress and psychological well being). The SF-12 will allow us to characterize the functional status of our sample.

  • World Health Organization Health & Work Performance Questionnaire (HPQ) [ Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks ] [ Designated as safety issue: No ]
    We will use the 21-item 7-day clinical trial version of the World Health Organization Health & Work Performance Questionnaire (HPQ) to measure the impact of DESTRESS-PC on occupational functioning. The HPQ is a self-report questionnaire that obtains information about three types of workplace consequences: absenteeism (missed work days due to illness), presenteeism (low performance at work), and critical incidents.

  • Patient Health Questionnaire (PHQ) [ Time Frame: Baseline, 12 weeks, 18 weeks, and 24 weeks ] [ Designated as safety issue: No ]
    The PHQ is a self-report assessment of common mental disorders developed specifically for primary care. PHQ allows brief provisional primary care diagnoses of a several disorders including major depression, panic disorder, other anxiety disorder, and multisomatoform disorder. We will use the PHQ for brief assessments of depression, anxiety (panic and generalized anxiety), and somatic symptom severity, assessments with excellent correspondence to DSM-IV diagnostic criteria.

  • Generalized Anxiety Symptom Severity (GAD-7) [ Time Frame: Baseline ] [ Designated as safety issue: No ]
    Generalized anxiety symptoms will be assessed using the GAD-7, a brief measure designed for use in general health settings.

  • Sheehan Disability Scale (SDS) [ Time Frame: baseline, 12 week, 18 week and 24 week ] [ Designated as safety issue: No ]
    The SDS is a three-item self-reporting tool measuring the impairment of a disability on work, social life and family life/home responsibilities. SDS is scored on a 10-point scale with 0 being "not at all disrupted" and being 10 "extremely disrupted" with any item scoring above 5 indicating a significant functional impairment in that domain. It has been used as an outcome measure in studies of PTSD due to its construct criterion related validity.

  • Alcohol Use Disorders Identification Test-Civilian version (AUDIT-C) [ Time Frame: baseline, 12 week, 18 week, and 24 week ] [ Designated as safety issue: No ]
    Audit-C is a brief screen that has been found to effectively discriminate between patients with a history of drinking problems and those without such a history, including hazardous drinking. Its brevity ensures that clinicians will remember it, and administration time is minimal. A positive total score is an indication for further screening and assessment

  • Numeric Rating Scale for Pain (NRS). [ Time Frame: baseline, 12 week, 18 week, and 24 week ] [ Designated as safety issue: No ]
    The NRS directs participants to rate pain intensity using three, 11-point, 0 ("no pain") to 10 ("pain as bad as you can imagine") numeric rating scales. Instructions ask participants to "Please rate your pain by indicating the number that best describes your pain on average in the last 24 hours", pain "at its worst", and "pain at its least". The NRS will be used in this study to evaluate the effect of acupuncture on comorbid symptoms of pain.


Estimated Enrollment: 91
Study Start Date: January 2012
Estimated Study Completion Date: January 2014
Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: DESTRESS-T
Usual primary care PTSD treatment, plus a telephone care management program over 8 weeks that includes: four outreach calls, feedback to the treating primary care provider, and care coordination
Behavioral: DESTRESS-T
Usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider, and care coordination
Other Name: Delivery of Self-Training for Stressful Situations, Telephonic version
Active Comparator: Optimized Usual Care (OUC)
Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.
Other: Optimized Usual Care (OUC)
Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.

Detailed Description:

This is a randomized controlled trial that will compare DESTRESS-T to Optimized Usual Care (OUC). Optimized Usual Care is usual primary care PTSD treatment, plus a telephone care management program that includes: four outreach calls, feedback to the treating primary care provider (PCP), and care coordination.

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age>18 years
  • DSM-IV diagnosis of PTSD (derived from the CAPS) due to combat in OIF/OEF deployment
  • Active duty personnel

Exclusion Criteria:

  • Active suicidal or violent ideation within the past two months as assessed by the MINI and a supplementary form developed by the project team (see Appendices)
  • Current participation in any active psychotherapy (e.g., psychoanalysis, CBT) for mood, anxiety or substance use disorders (as determined via service member self report and/or check of medical record)
  • Recurrent PTSD treatment failure in psychotherapy, as determined via consensus of study team members (Dr. Charles Engel, Dr. Brett Litz, and Dr. Kristie Gore)
  • Current alcohol dependence, as assessed by MINI
  • Acute psychosis, psychotic episode, or psychotic disorder diagnosis within the past year, as assessed by the MINI
  • Currently on an antipsychotic or mood-stabilizing agent for bipolar disorder or any disorder with psychotic features, as determined by medical record and/or self report
  • Unstable administration schedule or dosing of any antidepressant, anxiolytic, or sedative-hypnotic (i.e., will exclude for any related medication changes in the month prior to randomization), as determined by medical record or service member self report
  • Acute or unstable physical illness based on the judgment of the patient's primary care clinician and the study team.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01502449

Contacts
Contact: Elizabeth Harper Cordova, MA 301-295-7339 elizabeth.harper1@us.army.mil
Contact: Kristie Gore, Ph.D. 301-295-7351 kristie.gore@us.army.mil

Locations
United States, Georgia
Fort Benning - Martin Army Community Hospital Not yet recruiting
Columbus, Georgia, United States, 31905
Contact: Kristie L. Gore, Ph.D.     301-295-7351     kristie.gore@us.army.mil    
Contact: Elizabeth Harper Cordova, MA     301-295-7339     elizabeth.harper1@us.army.mil    
Principal Investigator: Sharon A. Maxwell, MD            
Sponsors and Collaborators
Uniformed Services University of the Health Sciences
Walter Reed National Military Medical Center
Investigators
Principal Investigator: COL Charles C. Engel, MD, MPH Uniformed Services University of the Health Sciences
  More Information

No publications provided

Responsible Party: Charles Engel, Dir., Deployment Health Clinical Center; Associate Professor, psychiatry, USUHS, Uniformed Services University of the Health Sciences
ClinicalTrials.gov Identifier: NCT01502449     History of Changes
Other Study ID Numbers: D10-I-AR-J5-786
Study First Received: December 12, 2011
Last Updated: January 11, 2012
Health Authority: United States: Federal Government
United States: Institutional Review Board

Keywords provided by Uniformed Services University of the Health Sciences:
telemedicine, telephonic, PTSD

Additional relevant MeSH terms:
Stress Disorders, Post-Traumatic
Stress Disorders, Traumatic
Anxiety Disorders
Mental Disorders

ClinicalTrials.gov processed this record on May 16, 2013